메뉴 건너뛰기




Volumn 148, Issue 5, 2015, Pages 1268-1275

Predicting mortality in systemic sclerosis-associated interstitial lung disease using risk prediction models derived from idiopathic pulmonary fibrosis

Author keywords

[No Author keywords available]

Indexed keywords

6 MIN WALK TEST; ADULT; ARTICLE; CALIBRATION; COMPOSITE PHYSIOLOGIC INDEX; DU BOIS INDEX; ECHOCARDIOGRAPHY; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; FUNCTION TEST; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL LUNG DISEASE GENDER AGE PHYSIOLOGY INDEX; LOGISTIC REGRESSION ANALYSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MODIFIED DU BOIS INDEX; MORTALITY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT DISEASE ASSESSMENT; RETROSPECTIVE STUDY; SURVIVAL; SYSTEMIC SCLEROSIS; SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE; CANADA; COMPLICATION; EPIDEMIOLOGY; FOLLOW UP; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TIME; TRENDS; VITAL CAPACITY;

EID: 84946562647     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.15-0003     Document Type: Article
Times cited : (46)

References (23)
  • 1
    • 4143111667 scopus 로고    scopus 로고
    • Introduction: Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines
    • Rubin LJ. Introduction: diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004; 126 (1- s uppl): 7S-10S.
    • (2004) Chest. , vol.126 , Issue.1 , pp. 7S-10S
    • Rubin, L.J.1
  • 2
    • 33947697880 scopus 로고    scopus 로고
    • The natural course of progressive systemic sclerosis patients with interstitial lung involvement
    • Benan M, Hande I, Gul O. The natural course of progressive systemic sclerosis patients with interstitial lung involvement. Clin Rheumatol. 2007; 26 (3): 349-354.
    • (2007) Clin Rheumatol. , vol.26 , Issue.3 , pp. 349-354
    • Benan, M.1    Hande, I.2    Gul, O.3
  • 3
    • 0038799767 scopus 로고    scopus 로고
    • Interstitial lung disease in scleroderma
    • White B. Interstitial lung disease in scleroderma. Rheum Dis Clin North Am. 2003; 29 (2): 371-390.
    • (2003) Rheum Dis Clin North Am. , vol.29 , Issue.2 , pp. 371-390
    • White, B.1
  • 4
    • 34347266509 scopus 로고    scopus 로고
    • Changes in causes of death in systemic sclerosis, 1972-2002
    • Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis. 2007; 66 (7): 940-944.
    • (2007) Ann Rheum Dis. , vol.66 , Issue.7 , pp. 940-944
    • Steen, V.D.1    Medsger, T.A.2
  • 5
    • 84905647871 scopus 로고    scopus 로고
    • Predictors of mortality and progression in scleroderma-associated interstitial lung disease: A systematic review
    • Winstone TA, Assayag D, Wilcox PG, et al. Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review. Chest. 2014; 146 (2): 422-436.
    • (2014) Chest. , vol.146 , Issue.2 , pp. 422-436
    • Winstone, T.A.1    Assayag, D.2    Wilcox, P.G.3
  • 6
    • 79952717349 scopus 로고    scopus 로고
    • An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management
    • Raghu G, Collard HR, Egan JJ, et al; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183 (6): 788-824.
    • (2011) Am J Respir Crit Care Med. , vol.183 , Issue.6 , pp. 788-824
    • Raghu, G.1    Collard, H.R.2    Egan, J.J.3
  • 7
    • 84861162888 scopus 로고    scopus 로고
    • A multidimensional index and staging system for idiopathic pulmonary fibrosis
    • Ley B, Ryerson CJ, Vittinghoff E, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012; 156 (10): 684-691.
    • (2012) Ann Intern Med. , vol.156 , Issue.10 , pp. 684-691
    • Ley, B.1    Ryerson, C.J.2    Vittinghoff, E.3
  • 8
    • 0037383987 scopus 로고    scopus 로고
    • Idiopathic pulmonary fibrosis: A composite physiologic index derived from disease extent observed by computed tomography
    • Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med. 2003; 167 (7): 962-969.
    • (2003) Am J Respir Crit Care Med. , vol.167 , Issue.7 , pp. 962-969
    • Wells, A.U.1    Desai, S.R.2    Rubens, M.B.3
  • 9
    • 80051819865 scopus 로고    scopus 로고
    • Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis
    • du Bois RM, Weycker D, Albera C, et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011; 184 (4): 459-466.
    • (2011) Am J Respir Crit Care Med. , vol.184 , Issue.4 , pp. 459-466
    • Du Bois, R.M.1    Weycker, D.2    Albera, C.3
  • 10
    • 84899830690 scopus 로고    scopus 로고
    • 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis
    • du Bois RM, Albera C, Bradford WZ, et al. 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2014; 43 (5): 1421-1429.
    • (2014) Eur Respir J. , vol.43 , Issue.5 , pp. 1421-1429
    • Du Bois, R.M.1    Albera, C.2    Bradford, W.Z.3
  • 11
    • 84898755329 scopus 로고    scopus 로고
    • Predicting survival across chronic interstitial lung disease: The ILD-GAP model
    • Ryerson CJ, Vittinghoff E, Ley B, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest. 2014; 145 (4): 723-728.
    • (2014) Chest. , vol.145 , Issue.4 , pp. 723-728
    • Ryerson, C.J.1    Vittinghoff, E.2    Ley, B.3
  • 12
    • 84886777196 scopus 로고    scopus 로고
    • 2013 classification criteria for systemic sclerosis: An American College of Rheumatology/European League against Rheumatism collaborative initiative
    • van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013; 65 (11): 2737-2747.
    • (2013) Arthritis Rheum. , vol.65 , Issue.11 , pp. 2737-2747
    • Van Den Hoogen, F.1    Khanna, D.2    Fransen, J.3
  • 13
    • 0018887574 scopus 로고
    • Preliminary criteria for the classification of systemic sclerosis (scleroderma)
    • Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee
    • Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980; 23 (5): 581-590.
    • (1980) Arthritis Rheum. , vol.23 , Issue.5 , pp. 581-590
  • 14
    • 84881669432 scopus 로고    scopus 로고
    • An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias
    • Travis WD, Costabel U, Hansell DM, et al; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013; 188 (6): 733-748.
    • (2013) Am J Respir Crit Care Med. , vol.188 , Issue.6 , pp. 733-748
    • Travis, W.D.1    Costabel, U.2    Hansell, D.M.3
  • 15
    • 21744439879 scopus 로고    scopus 로고
    • Standardisation of the single-breath determination of carbon monoxide uptake in the lung
    • Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005; 26 (4): 720-735.
    • (2005) Eur Respir J. , vol.26 , Issue.4 , pp. 720-735
    • Macintyre, N.1    Crapo, R.O.2    Viegi, G.3
  • 16
    • 21744460289 scopus 로고    scopus 로고
    • Standardisation of spirometry
    • Miller MR, Hankinson J, Brusasco V, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005; 26 (2): 319-338.
    • (2005) Eur Respir J. , vol.26 , Issue.2 , pp. 319-338
    • Miller, M.R.1    Hankinson, J.2    Brusasco, V.3
  • 17
    • 21744434300 scopus 로고    scopus 로고
    • Standardisation of the measurement of lung volumes
    • Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005; 26 (3): 511-522.
    • (2005) Eur Respir J. , vol.26 , Issue.3 , pp. 511-522
    • Wanger, J.1    Clausen, J.L.2    Coates, A.3
  • 18
    • 0036644465 scopus 로고    scopus 로고
    • ATS statement: Guidelines for the six-minute walk test
    • ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166 (1): 111-117.
    • (2002) Am J Respir Crit Care Med. , vol.166 , Issue.1 , pp. 111-117
  • 19
    • 67650349068 scopus 로고    scopus 로고
    • Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): A multicentre randomised placebo-controlled trial
    • King TE Jr, Albera C, Bradford WZ, et al; INSPIRE Study Group. effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet. 2009; 374 (9685): 222-228.
    • (2009) Lancet. , vol.374 , Issue.9685 , pp. 222-228
    • King, T.E.1    Albera, C.2    Bradford, W.Z.3
  • 20
    • 0345824715 scopus 로고    scopus 로고
    • A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
    • Raghu G, Brown KK, Bradford WZ, et al; Idiopathic Pulmonary Fibrosis Study Group. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2004; 350 (2): 125-133.
    • (2004) N Engl J Med. , vol.350 , Issue.2 , pp. 125-133
    • Raghu, G.1    Brown, K.K.2    Bradford, W.Z.3
  • 21
    • 44449152061 scopus 로고    scopus 로고
    • Interstitial lung disease in systemic sclerosis: A simple staging system
    • Goh NS, Desai SR, Veeraraghavan S, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med. 2008; 177 (11): 1248-1254.
    • (2008) Am J Respir Crit Care Med. , vol.177 , Issue.11 , pp. 1248-1254
    • Goh, N.S.1    Desai, S.R.2    Veeraraghavan, S.3
  • 22
    • 84055212479 scopus 로고    scopus 로고
    • Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease
    • De Santis M, Bosello SL, Peluso G, et al. Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease. Clin Respir J. 2012; 6 (1): 9-17.
    • (2012) Clin Respir J. , vol.6 , Issue.1 , pp. 9-17
    • De Santis, M.1    Bosello, S.L.2    Peluso, G.3
  • 23
    • 84871132776 scopus 로고    scopus 로고
    • Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease
    • Moore OA, Goh N, Corte T, et al. Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford). 2013; 52 (1): 155-160.
    • (2013) Rheumatology (Oxford). , vol.52 , Issue.1 , pp. 155-160
    • Moore, O.A.1    Goh, N.2    Corte, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.